C1q Nephropathy - A profile
Abstract
AbstractBackground C1q nephropathy is
an under diagnosed disease with varied
clinical presentation. Diagnostic criteria
of C1q nephropathy 1. Dominant or
codominat immunoflurescent staining for
c1q in kidney biopsy2. Mesangial electron
dense deposits 3. No clinical and
serological evidence of SLE.Materials
and methods 13 patients who satisfied
the above criteria were studied. Clinical
profile and laboratory parameters including
urine analysis, urine spot PCR, blood
biochemistry, serum complement and
histopathological profile were analyzed.
Creatinine clearance was estimated using
Cockgraut Gault formula. They were
followed followed up for assessment of
response to treatment.Results Among
the 13 patients 12 were female (92.3). All
(100) were hypertensive at the time of
presentation. Age ranged from 15 to 48
yrs with mean of 34 yrs. Microscopic
haematuria was found in all 13 patients (
(100) Nephrotic proteinuria was found 10
patients (77) and 4 patients (30.7) had
GFR60mlmin. Kidney biopsy revealed
Diffuse Proliferative Glomerular Nephrits
in 12 patients (92.3) one patient had
FSGS (7.7). Cellular crescents were
found in 2 patients (15.3). One patient
was lost for follow-up. 3 patients (25) improved
with ACE inhibitors and statins. 9
patients (69.2) were started on steroids
of which the 4 patients who had renal failure
received cyclophosphamide in addition
to steroids. Of the 9 patients, complete
remission was found in 2 patients
(22) , partial remission in 2 patient(22)
and no response to immunosuppressive
mediation was found in 5 patients(55.5)
( 1 patient had FSGS and 4 patients had
DPGN)Conclusion among the 13 cases
with c1q nephropathy1.All patients had
hypertension and microscopic hamaturia.
2.Nephrotic proteinuria was seen in
three fourth of the patients3.Commonest
histopathological presentation was diffuse
proliferative Glomerulonephrits.4.Half of the
patients showed poor response to oral steroids
Full Text:
PDFReferences
Jennette JC, Hipp CG. C1q nephropathy:
a distinct pathologic entity usually
causing nephritic syndrome. Am K Kidney
Dis1985; 6: 103–110
Jennette JC, Wilkman AS, Hogan SL,
Falk RJ. Clinical and pathologic features of
C1q nephropathy [abstract]. J Am Soc
Nephrol 1993; 4: 681A.
Cairns SA, Acheson EJ, Corbett CL et
al. The delayed appearance of an antinuclear
factor and the diagnosis of systemic
lupus erythematosus in glomerulonephritis.
PostgradMed J 1979; 55: 723–727
Adu D, Williams DG, Taube D et al. Late
onset systemic lupus erythematosus and
lupus-like disease in patients with apparent
idiopathic glomerulonephritis. Q J Med
; 52: 471–487
Markowitz GS, Schwimmer JA, Stokes
MB, Nasr S, Seigle RL, Valeri AM, D’Agati
VD: C1q nephropathy: A variant of focal
segmental glomerulosclerosis. Kidney Int
: 1232–1240, 2003
Iskandar SS, Browning MC, Lorentz WB:
C1q nephropathy: A pediatric clinicopathologic
study. Am J Kidney Dis 18: 459–
, 1991
Jennette JC, Hipp CG: Immunohistopathologic
evaluation of C1q in 800 renal biopsy
specimens. Am J Clin Pathol 83:415–
, 1985
Emancipator SN: Benign essential hematuria,
IgA nephropathy, and Alport syndrome.
In: Renal Biopsy Interpretation, edited
by Silva FG, D’Agati VD, Nadasdy T, New
York, Churchill Livingstone, 1996, pp 147–180
Sinico RA, Bollini B, Sabadini E, Di
Toma L, Radice A. The use of laboratory
tests in the diagnosis and monitoring of
systemic lupus erythematosus. J Nephrol
; 15 [Suppl 6]: S20–S27
Sharman A, Furness P, Feehally J: Distinguishing
C1q nephropathy from lupus
nephritis. Nephrol Dial Transplant 19: 1420–
, 2004
Iskandar SS, Browning MC, Lorentz WB:
C1q nephropathy: A pediatric clinicopathologic
study. Am J Kidney Dis 18:459–
,
Davenport A, Maciver AG, Mackenzie
JC: C1q nephropathy: Do C1q deposits
have any prognostic significance in the
nephrotic syndrome? Nephrol Dial Transplant
:391–396, 1992
Andrew Sharman, Peter Furness and
John Feehally Nephrol Dial Transplant
(2004) 19: 1420–1426
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An initiative of The Tamil Nadu Dr M.G.R. Medical University